|
1
|
Gianferante DM, Mirabello L and Savage SA:
Germline and somatic genetics of osteosarcoma-connecting aetiology,
biology and therapy. Nat Rev Endocrinol. 13:480–491. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Basu-Roy U, Basilico C and Mansukhani A:
Perspectives on cancer stem cells in osteosarcoma. Cancer Lett.
338:158–167. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Geller DS and Gorlick R: Osteosarcoma: A
review of diagnosis, management, and treatment strategies. Clin Adv
Hematol Oncol. 8:705–718. 2010.PubMed/NCBI
|
|
4
|
Ferrari S, Palmerini E, Staals EL, Mercuri
M, Franco B, Picci P and Bacci G: The treatment of nonmetastatic
high grade osteosarcoma of the extremity: Review of the italian
rizzoli experience. impact on the future. Cancer Treat Res.
152:275–287. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the surveillance, epidemiology, and end results program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Meazza C and Scanagatta P: Metastatic
osteosarcoma: A challenging multidisciplinary treatment. Expert Rev
Anticancer Ther. 16:543–556. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pillai RS, Bhattacharyya SN and Filipowicz
W: Repression of protein synthesis by miRNAs: How many mechanisms?
Trends Cell Biol. 17:118–126. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Valencia-Sanchez MA, Liu J, Hannon GJ and
Parker R: Control of translation and mRNA degradation by miRNAs and
siRNAs. Genes Dev. 20:515–524. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang F, Ning Z, Ma L, Liu W, Shao C, Shu Y
and Shen H: Exosomal miRNAs and miRNA dysregulation in
cancer-associated fibroblasts. Mol Cancer. 16:1482017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ribeiro AO, Schoof CR, Izzotti A, Pereira
LV and Vasques LR: MicroRNAs: Modulators of cell identity, and
their applications in tissue engineering. Microrna. 3:45–53. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bai C, Li X, Gao Y, Wang K, Fan Y, Zhang
S, Ma Y and Guan W: Role of microRNA-21 in the formation of
insulin-producing cells from pancreatic progenitor cells. Biochim
Biophys Acta. 1859:280–293. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bai C, Li X, Gao Y, Yuan Z, Hu P, Wang H,
Liu C, Guan W and Ma Y: Melatonin improves reprogramming efficiency
and proliferation of bovine-induced pluripotent stem cells. J
Pineal Res. 61:154–167. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bai C, Gao Y, Li X, Wang K, Xiong H, Shan
Z, Zhang P, Wang W, Guan W and Ma Y: MicroRNAs can effectively
induce formation of insulin-producing cells from mesenchymal stem
cells. J Tissue Eng Regen Med. 11:3457–3468. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jiashi W, Chuang Q, Zhenjun Z, Guangbin W,
Bin L and Ming H: MicroRNA-506-3p inhibits osteosarcoma cell
proliferation and metastasis by suppressing RAB3D expression. Aging
(Albany NY). 10:1294–1305. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li G, Li L, Sun Q, Wu J, Ge W, Lu G and
Cai M: MicroRNA-3200-5p promotes osteosarcoma cell invasion via
suppression of BRMS1. Mol Cells. 41:523–531. 2018.PubMed/NCBI
|
|
16
|
Lei W, Yan C, Ya J, Yong D, Yujun B and
Kai L: miR-199a-3p affects the multi-chemoresistance of
osteosarcoma through targeting AK4. BMC Cancer. 18:6312018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kushlinskii NE, Fridman MV and Braga EA:
Molecular mechanisms and microRNAs in osteosarcoma pathogenesis.
Biochemistry (Mosc). 81:315–328. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen L, Kong G, Zhang C, Dong H, Yang C,
Song G, Guo C, Wang L and Yu H: MicroRNA-432 functions as a tumor
suppressor gene through targeting E2F3 and AXL in lung
adenocarcinoma. Oncotarget. 7:20041–20053. 2016.PubMed/NCBI
|
|
19
|
Das E and Bhattacharyya NP: MicroRNA-432
contributes to dopamine cocktail and retinoic acid induced
differentiation of human neuroblastoma cells by targeting NESTIN
and RCOR1 genes. FEBS Lett. 588:1706–1714. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jiang N, Chen WJ, Zhang JW, Xu C, Zeng XC,
Zhang T, Li Y and Wang GY: Downregulation of miR-432 activates
Wnt/β-catenin signaling and promotes human hepatocellular carcinoma
proliferation. Oncotarget. 6:7866–7879. 2015.PubMed/NCBI
|
|
21
|
Li JB, Liu F, Zhang BP, Bai WK, Cheng W,
Zhang YH and Yu LJ: LncRNA625 modulates prostate cancer cells
proliferation and apoptosis through regulating the Wnt/β-catenin
pathway by targeting miR-432. Eur Rev Med Pharmacol Sci.
21:2586–2595. 2017.PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang K, Zhang Y, Zhu H, Xue N, Liu J,
Shan C and Zhu Q: High expression of MACC1 predicts poor prognosis
in patients with osteosarcoma. Tumour Biol. 35:1343–1350. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang K, Tian F, Zhang Y, Zhu Q, Xue N,
Zhu H, Wang H and Guo X: MACC1 is involved in the regulation of
proliferation, colony formation, invasion ability, cell cycle
distribution, apoptosis and tumorigenicity by altering Akt
signaling pathway in human osteosarcoma. Tumour Biol. 35:2537–2548.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang J, Yan YG, Wang C, Zhang SJ, Yu XH
and Wang WJ: MicroRNAs in osteosarcoma. Clin Chim Acta. 444:9–17.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sampson VB, Yoo S, Kumar A, Vetter NS and
Kolb EA: MicroRNAs and potential targets in osteosarcoma: Review.
Front Pediatr. 3:692015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang H, Tang M, Ou L, Hou M, Feng T, Huang
YE, Jin Y, Zhang H and Zuo G: Biological analysis of cancer
specific microRNAs on function modeling in osteosarcoma. Sci Rep.
7:53822017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou G, Shi X, Zhang J, Wu S and Zhao J:
MicroRNAs in osteosarcoma: From biological players to clinical
contributors, a review. J Int Med Res. 41:1–12. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jorissen RN, Gibbs P, Christie M, Prakash
S, Lipton L, Desai J, Kerr D, Aaltonen LA, Arango D, Kruhøffer M,
et al: Metastasis-associated gene expression changes predict poor
outcomes in patients with dukes stage B and C colorectal cancer.
Clin Cancer Res. 15:7642–7651. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tang J, Chen JX, Chen L, Tang JY, Cui Z,
Liu CH and Wang Z: Metastasis associated in colon cancer 1 (MACC1)
promotes growth and metastasis processes of colon cancer cells. Eur
Rev Med Pharmacol Sci. 20:2825–2834. 2016.PubMed/NCBI
|
|
31
|
Chen S, Zong ZH, Wu DD, Sun KX, Liu BL and
Zhao Y: The role of metastasis-associated in colon cancer 1 (MACC1)
in endometrial carcinoma tumorigenesis and progression. Mol
Carcinog. 56:1361–1371. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang Z, Li Z, Wu C, Wang Y, Xia Y, Chen L,
Zhu Q and Chen Y: MACC1 overexpression predicts a poor prognosis
for non-small cell lung cancer. Med Oncol. 31:7902014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sun DW, Zhang YY, Qi Y, Liu GQ, Chen YG,
Ma J and Lv GY: Prognostic and clinicopathological significance of
MACC1 expression in hepatocellular carcinoma patients:
Ameta-analysis. Int J Clin Exp Med. 8:4769–4777. 2015.PubMed/NCBI
|
